EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elevated PAF1-RAD52 axis confers chemoresistance to human cancers

Sanchita Rauth, Koelina Ganguly, Pranita Atri, Seema Parte, Rama Krishna Nimmakayala, Venkatesh Varadharaj, Palanisamy Nallasamy, Raghupathy Vengoji, Ayoola O Ogunleye, Imayavaramban Lakshmanan, Ramakanth Chirravuri, Mika Bessho und 7 weitere

Cell Reports · 2023-02 · 42 (2) · 112043

DOI: 10.1016/j.celrep.2023.112043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-02. Verfasst von Sanchita Rauth und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmLung NeoplasmsHumansCell Line, TumorCisplatinDeoxycytidineGemcitabineRad52 DNA Repair and Recombination ProteinTranscription Factors

Stichwörter der Autor:innen

CP: CancerDNA repairPAF1RAD52chemoresistancelung cancerovarian cancerpancreatic cancer

Substanzen

CisplatinDeoxycytidineGemcitabinePAF1 protein, humanRad52 DNA Repair and Recombination ProteinRAD52 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
  • Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
  • Department of Pathology and Microbiology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
  • Department of Surgery, University of Nebraska Medical Center at Omaha, Omaha, NE, USA.
  • Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA; Division of Oncology-Hematology, Department of Internal Medicine, VA Nebraska Western Iowa Health Care Sy…
  • Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center at Omaha, Omaha, NE, USA; Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, Unive…

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • NCI
  • Nebraska Department of Health and Human Services

Zitieren

APA

Rauth, S., Ganguly, K., Atri, P., Parte, S., Nimmakayala, R. K., Varadharaj, V., Nallasamy, P., Vengoji, R., Ogunleye, A. O., Lakshmanan, I., Chirravuri, R., Bessho, M., Cox, J. L., Foster, J. M., Talmon, G. A., Bessho, T., Ganti, A. K., Batra, S. K., & Ponnusamy, M. P. (2023). Elevated PAF1-RAD52 axis confers chemoresistance to human cancers. Cell Reports, 42(2), 112043. https://doi.org/10.1016/j.celrep.2023.112043

Vancouver

Rauth S, Ganguly K, Atri P, Parte S, Nimmakayala RK, Varadharaj V, et al. Elevated PAF1-RAD52 axis confers chemoresistance to human cancers. Cell Reports. 2023;42(2):112043. doi:10.1016/j.celrep.2023.112043

BibTeX
@article{Rauth2023,
  author = {Rauth, Sanchita and Ganguly, Koelina and Atri, Pranita and Parte, Seema and Nimmakayala, Rama Krishna and Varadharaj, Venkatesh and Nallasamy, Palanisamy and Vengoji, Raghupathy and Ogunleye, Ayoola O and Lakshmanan, Imayavaramban and Chirravuri, Ramakanth and Bessho, Mika and Cox, Jesse L and Foster, Jason M and Talmon, Geoffrey A and Bessho, Tadayoshi and Ganti, Apar Kishor and Batra, Surinder K and Ponnusamy, Moorthy P},
  title = {Elevated PAF1-RAD52 axis confers chemoresistance to human cancers},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {2},
  pages = {112043},
  doi = {10.1016/j.celrep.2023.112043}
}
Kostenlos starten →